Search results for PX-TA1396
Showing 1 – 10 of1products

ID: BAB744223505
Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade, ProteoGenix, PX-TA1396
Description of Risankizumab Biosimilar - Anti-IL23A mAb - Research Grade General information on Anti-IL23A[Homo sapiens] (Risankizumab) Monoclonal Antibody Risankizumab is a humanized IgG1 monoclonal antibody (mAb) that targets interleukin 23 (IL-23). It has been used for the treatment of moderate-to-severe plaque psoriasis
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
